The European Union Horizon 2020 research and innovation program has awarded a 2.4 million euros grant to Israel’s Tarsius. Tarsius’s new molecule “re-engineers” the immune system to treat autoimmune and inflammatory ocular diseases that can eventually cause blindness.
https://www.calcalistech.com/ctech/articles/0,7340,L-3770582,00.html